Related Experiment Video

Updated: Aug 18, 2026

Generation of Lymphocytic Microparticles and Detection of their Proapoptotic Effect on Airway Epithelial Cells
09:26

Generation of Lymphocytic Microparticles and Detection of their Proapoptotic Effect on Airway Epithelial Cells

Published on: February 20, 2015

[Microparticles and cardiovascular disease]

O Morel1, P Ohlmann, N Morel

  • 1Fédération de cardiologie des Hôpitaux universitaires de Strasbourg, service de cardiologie, Hôpital de Haute-Pierre, Strasbourg. Olivier.Morel@chru-strasbourg.fr

Archives Des Maladies Du Coeur Et Des Vaisseaux
|April 9, 2005
PubMed

Insights

Microparticles, cell fragments once dismissed as debris, are now recognized as key players in vascular functions like thrombosis and inflammation. Targeting these circulating microparticles may offer future therapeutic strategies for cardiovascular diseases.

Area of Science:

  • Cell biology
  • Vascular biology
  • Biochemistry

Context:

  • Microparticles are membrane fragments released from activated or apoptotic cells.
  • Previously considered non-functional cellular debris.
  • They play significant roles within the vascular system.

Purpose:

  • To highlight the biological significance of microparticles in vascular functions.
  • To underscore their role in thrombosis, inflammation, vascular remodeling, and angiogenesis.
  • To explore their potential as therapeutic targets.

Summary:

  • Circulating microparticles act as reservoirs of cellular effectors in the bloodstream.
  • Elevated levels of procoagulant microparticles are observed in cardiovascular diseases.
  • These microparticles are linked to platelet, endothelial, and monocyte activation.

Impact:

  • Microparticle concentrations are implicated in the pathogenesis of atherothrombotic disease.
  • Understanding microparticle function is crucial for cardiovascular research.
  • Pharmacological targeting of microparticles presents a potential future therapeutic avenue.

More Related Videos

Fundus Photography as a Convenient Tool to Study Microvascular Responses to Cardiovascular Disease Risk Factors in Epidemiological Studies10:11

Fundus Photography as a Convenient Tool to Study Microvascular Responses to Cardiovascular Disease Risk Factors in Epidemiological Studies

Published on: October 22, 2014

Related Concept Videos

Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers01:19

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
Inflammation01:38

Inflammation

Overview